Creating a tuberculosis patient portal for tertiary care facilities in Southern India
Not Applicable
- Registration Number
- CTRI/2024/01/061325
- Lead Sponsor
- Intramural Funding, MAHE, Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Microbiologically confirmed pulmonary and extrapulmonary TB cases
2) Inpatients
Exclusion Criteria
1) TB patient with mental illness
2) Pregnant women with TB
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The study could provide valuable information on the impact of M. tuberculosis lineage, antitubercular resistance, and demographic, and clinical data on TB patients’ outcomes. <br/ ><br>2. Comprehensive surveillance by WGS could complement phenotypic DST in selecting precise antitubercular drug therapy for TB patients. <br/ ><br>3. Lineage-specific variations could help decipher drug resistance mutations.Timepoint: 3 years
- Secondary Outcome Measures
Name Time Method The study could add important information for regional and national policymaking for appropriate antitubercular drug and dose selectionTimepoint: 3 years